Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 4 1Phase 2 1

Status

Completed 15Unknown 5Active not recruiting 5Terminated 4Recruiting 3Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 3OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Genitourinary 5Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 3Recurrence 1Prostatic Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1

Interventions

Docetaxel 33Radiosurgery 23Radiotherapy 21Sunitinib 20pembrolizumab 18Gemcitabine 16Cisplatin 16Androgen Antagonists 15Nivolumab 14enzalutamide 13Goserelin 13Prednisone 12Leuprolide 12Blood Specimen Collection 12Abiraterone Acetate 12bicalutamide 11aldesleukin 11Surveys and Questionnaires 11Cyclophosphamide 11Gonadotropin-Releasing Hormone 10Bevacizumab 10Multiparametric Magnetic Resonance Imaging 9Carboplatin 9acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 8Triptorelin Pamoate 8Radiotherapy, Intensity-Modulated 8Filgrastim 8Epirubicin 8Chemotherapy, Adjuvant 8Brachytherapy 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × BCG Vaccine × Genitourinary × Clear all
NCT02948543 2023-06-18

BCG+MM

University of Sydney

Phase 3 Unknown
501 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT05332353 2022-04-18

Machine Learning-Based Prediction of BCG Response in High-Risk Non-Muscle Invasive Bladder Cancer Patients

Mansoura University

Unknown
100 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT03664869 2021-04-01

FB10

Turku University Hospital

Phase 3 Unknown
300 enrolled
Genitourinary

Urinary Bladder Neoplasms, Recurrence

NCT03790384 2018-12-31

MITOBCG

Azienda Ospedaliera "Sant'Andrea"

Phase 4 Unknown
140 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT00514072 2012-08-09

Vaccine Therapy in Treating Patients With Stage D0 Prostate Cancer

Kael-GemVax Co., Ltd.

Phase 2 Unknown
54 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡